Snapshot from Jun 28, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / United States — Food and Drug Administration / Riad Sherif

United States — Food and Drug Administration & Riad Sherif

1 shared events · Importance 3 · Last updated Jun 12, 2026

Importance
3
Shared Events
1
Actions
0
Sentiment
0
Live sentiment trends, interaction importance charts, and action volume tracking available on the Ergen Dashboard
Shared Events (1)
75
Tech
Oculis Presents Privosegtor Optic Neuritis Data
United States — Food and Drug Administration: The United States — Food and Drug Administration granted Breakthrough Therapy designation for Privosegtor, a key regulatory milestone that accelerates its development and potential approval.
Riad Sherif: Riad Sherif, as CEO of Oculis, is the presenter of the Privosegtor program, emphasizing the company's strategic direction and the potential of the drug.
Jun 11, 2026 · 7 articles
NEWSDESK
Explore this relationship live

Track how United States — Food and Drug Administration and Riad Sherif interact across events, view sentiment trends, and discover connected entities.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.